Ting-Jung Hsu

Dr. Ting-Jung Hsu

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

13 April 2021 in International Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
THTing-Jung Hsu
Ting-Jung Hsu
HYHsu‐Hang Yeh
Hsu‐Hang Yeh
CLChih‐Hung Lee
Chih‐Hung Lee
KLKwei-Lan Liu
Kwei-Lan Liu

5 March 2023 in Journal of Fungi
Verified
Journal Article
Open access
PDF file
THTing-Jung Hsu
Ting-Jung Hsu
CLChih-Hung Lee
Chih-Hung Lee
Background: The rising incidence of implantation mycoses and invasive fungal infections prompts the need for studies describing the latest trends of these diseases; however, the literature remains scarce from tropical Asia in recent years. We shared our 11-year clinical experience at a tertiary center in Southern Taiwan to improve physicians’ understanding of the diseases, which could help them assume appropriate management strategies. Patients and methods: Forty cases of pathology-proven cases of implantation mycoses and invasive fungal infections with cutaneous involvement were retrospectively reviewed. The epidemiology, patients’ characteristics, initial clinical impressions, fungal species, management, and outcomes were compared and reported. Results: Fonsecaea sp. was the most commonly (14%) involved species in implantation mycoses. The percentages of immunocompromised patients with implantation mycoses and invasive fungal infections were 26% and 60%, respectively. Additionally, 46% of patients with implantation mycoses had type 2 diabetes mellitus. The lesions were commonly mistaken for skin appendage tumors, skin cancers, and hyperkeratotic dermatoses. The prognosis was favorable for the implantation mycoses (83% showed clinical improvement) but bleak for the invasive fungal infections (100% mortality). Conclusions: Presentations of implantation mycoses and invasive fungal infections vary widely, and immunocompromised status and diabetes mellitus are important associated factors.

29 March 2022 in Dermatologic Therapy
Verified
Journal Article
Closed access
THTing-Jung Hsu
Ting-Jung Hsu
HYHsu‐Hang Yeh
Hsu‐Hang Yeh
KLKwei-Lan Liu
Kwei-Lan Liu

1 January 2025 in Dermatologic Therapy
Verified
Journal Article
Open access
YWYing-Hsiang Wang
Ying-Hsiang Wang
SLShang-Hung Lin
Shang-Hung Lin
YCYu-Wen Cheng
Yu-Wen Cheng
YYYi-Chien Yang
Yi-Chien Yang
THTing-Jung Hsu
Ting-Jung Hsu
Background: Current therapies for epidermal growth factor receptor inhibitor (EGFRI)–related paronychia demonstrate effectiveness; however, some patients respond poorly and experience recurrent painful granulation tissue, particularly in weight‐bearing areas such as the big toes. Based on promising results from our previous pilot study by Hsu and colleagues, novel kinesiology tape wrapping, which physically shields the inflamed periungual tissue from irritation by the nail plate, has emerged as a potentially effective adjunct therapy. Objectives: This open‐label, randomized‐controlled, single‐center study was aimed to evaluate the efficacy and safety of kinesiology tape wrapping in cancer patients with EGFRI‐related paronychia. Materials and Methods: Eligible participants were assigned to receive either kinesiology tape wrapping in combination with conventional therapies or conventional therapies alone for 12 weeks. Efficacy outcomes, including the reduction of subjective pain assessed by the numerical rating scale (NRS) and the objective single‐digit scoring system for paronychia related to oncologic treatments (single‐digit SPOT), as well as adverse events (AEs), were recorded at baseline and at Weeks 1, 2, 4, 8, and 12 postenrollment. Results: A total of 24 patients were randomized, of which, 22 qualified for analysis. The rate of continuous tape use was 36.3%. At Week 12, pain NRS scores showed no significant differences between groups, while patients treated with continuous or intermittent kinesiology tape wrapping demonstrated notably greater reductions in single‐digit SPOT scores compared to those receiving conventional therapy alone (NRS: 3.27 vs. 2.78, p = 0.586; single‐digit SPOT: 5.32 vs. 1.52, p = 0.022). No serious AEs were reported. Conclusion: Kinesiology tape wrapping is an effective and safe adjunct noninvasive therapy that offers additional benefits in managing EGFRI‐related paronychia. Further studies with longer follow‐ups and improved patient compliance may help fully evaluate its effectiveness in pain reduction. Trial Registration : ClinicalTrials.gov identifier: NCT06411093